Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Open-label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, and Activity of AUBE00 in Patients With Solid Tumors

NCT07030959 is registered in ClinicalTrials.gov with Chugai Pharmaceutical as lead sponsor.

NCT NCT07030959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07030959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Open-label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, and Activity of AUBE00 in Patients With Solid Tumors
Lead sponsor
Chugai Pharmaceutical
Phase
Phase 1
Overall status
Recruiting
Start date
June 5, 2025
Completion date
December 31, 2029
Enrollment
130 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors